NASAL ANTI-CANCER THERAPIES

Abstract: provided herein are methods for treating cancer comprising intranasal administration of an oncolytic virus or an oncolytic virus-based vector, comprised in a mesenchymal stem cell (msc), an msc-derived ev, or in an msc-derived bioxome. further, the mscs, msc-derived evs, or msc-derived bioxomes disclosed herein may be used for treating a central nervous system (cns) related disorder.

IPC: